Methods of regulating cannabinoid receptor activity-related disorders and diseases

摘要: This disclosure concerns the discovery of use fenoterol analogues for regulating cannabinoid (CB) receptor activity-related disorders and disease, such as dysregulated CB receptors, including treating a disorder or glioblastoma, hepatocellular carcinoma, liver cancer, colon and/or lung which is associated with altered activity. In one example, method includes administering to subject having at risk developing disease regulated by activity an effective amount analogue reduce more symptoms